Search
for

    Sort by

    Research 121–150 of 1000+

    1. The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial Journal of cachexia, sarcopenia and muscle · 2011 · 306 citations
    2. Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double Blind, Placebo-Controlled Trial1 The Journal of Clinical Endocrinology and Metabolism · 2000 · 94 citations
    3. Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial Pediatric Dermatology · 2023 · 48 citations
    4. Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double Blind, Placebo-Controlled Trial The Journal of Clinical Endocrinology and Metabolism · 2000 · 46 citations
    5. Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial Journal of Affective Disorders · 2019 · 45 citations
    6. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial Contraception · 2009 · 42 citations
    7. Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: A pilot, double-blind, randomized, placebo-controlled trial Journal of Dermatology · 2008 · 33 citations
    8. Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial The Journal of Urology · 2023 · 20 citations
    9. Comment on “Effect of Pumpkin Seed Oil on Hair Growth in Men with Androgenetic Alopecia: A Randomized, Double-Blind, Placebo-Controlled Trial” Evidence-based Complementary and Alternative Medicine · 2015 · 3 citations
    10. Cervi Parvum Cornu complex for men with lower urinary tract symptoms: a multicenter, randomized, double-blind, placebo-controlled trial Prostate International · 2023 · 1 citations
    11. Improvements in scalp elasticity and hair properties following supplementation with low-molecular-weight porcine placental peptides (Placenderm®): A randomized, double-blind, placebo-controlled clinical trial 2026
    12. A Novel Approach Against Male Pattern Hair Loss With Topical Dimethylglycine Sodium Salt (DMG‐Na) and Caffeine: Efficacy of a 24‐Week, Double‐Blind, Randomized, Placebo‐Controlled Trial Journal of Cosmetic Dermatology · 2025
    13. Heat‐treated <i>Limosilactobacillus fermentum</i>LM1020 with menthol, salicylic acid, and panthenol promotes hair growth and regulates hair scalp microbiome balance in androgenetic alopecia: A double‐blind, randomized and placebo‐controlled clinical trial Journal of cosmetic dermatology · 2024
    14. Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial Research Square (Research Square) · 2019
    15. Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial Research Square (Research Square) · 2019
    16. The efficacy and safety of BM-PHA for the correction of nasolabial folds: a multicenter, randomized, double-blind, split-face clinical trial Journal of Dermatological Treatment · 2019
    17. ISID1077 – Efficacy and safety of ENERGI-F701 solution versus 2% minoxidil solution for female pattern hair loss: a phase II, multi-center, randomized, double-blind, head-to-head, parallel trial 2023
    18. 1077 Efficacy and safety of ENERGI-F701 solution versus 2% minoxidil solution for female pattern hair loss: a phase II, multi-center, randomized, double-blind, head-to-head, parallel trial Journal of Investigative Dermatology · 2023
    19. Sesquiterpene-Enriched Extract of <i>Curcuma aeruginosa</i> Roxb. Retards Axillary Hair Growth: A Randomised, Placebo-Controlled, Double-Blind Study Skin Pharmacology and Physiology · 2018 · 5 citations
    20. A double-blind, placebo-controlled study of inositol in trichotillomania International clinical psychopharmacology · 2016 · 18 citations
    21. Tratamento da alopecia areata com corticóide tópico: estudo prospectivo randomizado duplo cego em crianças * Therapy of alopecia areata with topical corticosteroid: prospective double-blind controlled assay in children * 2003
    22. Safety and Clinical Efficacy of KūlarisTM, an Herbal Supplement for Mild to Severe Acne Vulgaris – A 12-Week Randomized, Double Blind, Placebo-Controlled Study Clinical Cosmetic and Investigational Dermatology · 2025
    23. The first clinical trial of topical application of procyanidin B‐2 to investigate its potential as a hair growing agent 2001 · 26 citations
    24. Use and Misuse of PRP: Clinical Trial Proposal to Help Find PRP’s True Efficacy Journal of dermatological research · 2018
    25. A Randomized Double‐Blind Controlled Evaluation of the Therapeutic Benefits of an Herbal Lip Hydrant Journal of Cosmetic Dermatology · 2025 · 2 citations
    26. The Role of Sesbania grandiflora-Derived Biotin and Bambusa arundinacea-Derived Silica Extracts in Promoting Hair, Skin, and Nail Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Study Cureus · 2025
    27. A randomized, double-blind, vehicle-controlled clinical study of hair regeneration using adipose-derived stem cell constituent extract in androgenetic alopecia Stem Cells Translational Medicine · 2020 · 25 citations
    28. Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study 2025
    29. Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study Journal of Dermatological Treatment · 2025
    30. Efficacy and safety of topical finasteride spray solution in the treatment of Chinese men with androgenetic alopecia: A phase III, multicenter, randomized, double-blind, placebo-controlled study Chinese Medical Journal · 2025